1. Study identifies blood-based DNA methylation signatures for prediabetes. 2. Involved 187 discovery and 146 replication cohorts. 3. Over 120,000 differentially methylated sites identified. 4. 1,557 CpG sites effectively predict cluster membership. 5. Study highlights reduced need for traditional glucose tolerance testing. 6. Clinical implications suggest broader population screening. 7. Future studies required for longitudinal validation.
Listen Tab content
Blood-based methylation profiles reproduced high-risk clusters without complex metabolic testing.
by Jess Allerton
March 4, 2026
Machine learning models applied to inpatient electronic health record data have predicted insulin needs more accurately than traditional guidelines.
March 4, 2026
Randomized trial links a voice-based virtual assistant to reduced distress and modest HbA1c improvements in older adults with type 2 diabetes
March 2, 2026
The growing ability of AI systems “to influence human biology and lifespan might have implications we are not yet able to grasp."
by Doug Brunk
February 25, 2026
